XML 14 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating activities:    
Net loss $ (7,407) $ (12,306)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 528 654
Operating lease right-of-use amortization 463 581
Stock-based compensation 2,119 8
Issuance of common stock to underwriter 667  
Change in credit loss allowance (547) 793
Change in fair value of convertible promissory notes 1,354 (1,116)
Change in fair value of warrant liabilities (2,761)  
Loss from initial recognition of common stock forward liability 586  
Gain on extinguishment of liability (14,636)  
Changes in operating assets and liabilities:    
Accounts receivable (895) (3,290)
Inventory (1,624) 1,816
Contract assets (1,659) (1,984)
Prepaid expenses and other current assets (21) 785
Other assets 70 87
Accounts payable (2,328) (744)
Contract liabilities 463 16
Accrued and other current liabilities (3,040) 7,387
Net defined benefit liabilities 674 328
Income tax payable 35 (135)
Lease liabilities (455) (797)
Other liabilities (275) (3)
Net cash used in operating activities (28,689) (7,920)
Investing activities:    
Purchases of property and equipment (185) (284)
Net cash used in investing activities (185) (284)
Financing activities:    
Proceeds from reverse recapitalization and PIPE Financing, net of transaction costs 17,238  
Proceeds from issuance of convertible promissory notes 16,290  
Proceeds from issuance of common stock under common stock purchase agreement 7,814  
Proceeds from issuance of common stock and common stock warrants in a private placement 2,240  
Proceeds from borrowings 3,696 7,604
Proceeds from exercise of stock options 13 23
Repayments of borrowings (14,065) (23)
Repayments of convertible promissory notes (1,630)  
Payments of financial lease liabilities   (13)
Net cash provided by financing activities 31,596 7,591
Effect of exchange rate changes on cash and cash equivalents (1,168) (665)
Net increase (decrease) in cash and cash equivalents 1,554 (1,278)
Cash and cash equivalents at beginning of period 258 1,398
Cash and cash equivalents at end of period 1,812 120
Supplemental disclosure of cash flow information:    
Cash paid for interest 3,059 1,515
Cash paid for income taxes 212 47
Cash paid for operating leases 562 797
Non-cash financing activities:    
Issuance of common stock from conversion of convertible promissory notes 41,209 72
Settlement of common stock forward liability in equity 135  
Proceeds from issuance of common stock withheld for outstanding payables 975  
Operating lease right-of-use assets obtained in exchange for operating lease liabilities $ 54 $ 1,473